Get New Picks of the Market's Top Stocks Inovio Pharmaceuticals Inc INO shares are trading lower by 40% to $2.23 during Friday’s session after the company priced a public offering of 10 million ...

Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...

Internuclear ophthalmoplegia is common in MS and results from damage to interneurons travelling from the cranial nerve (CN) VI nucleus in the pons to the contralateral medial rectus subnucleus of ...

Neuroophthalmologic abnormalities associated with multiple sclerosis, including acute demyelinating optic neuritis and internuclear ophthalmoplegia, are described in detail. Current and emerging ...

Merck & Co. Inc.-0.12% $253.12B ...